Centre for the Commercialization of Antibodies and Biologics (CCAB)

The Centre for the Commercialization of Antibodies and Biologics (CCAB) provides expertise in product and business development to rapidly translate inventions toward achieving a real impact within the healthcare system and the broader scientific research community. Combining in-house capacities in the development of therapeutics, diagnostics and reagents, with the support of start-up companies in these areas, CCAB aims to: - Help create new companies to build and sustain Canada’s economic footprint in the life sciences and biotechnology sector; - Stimulate an increase in domestic and international partnerships and investments in Canada’s life sciences and biotechnology sector; and - Develop novel diagnostics and therapeutics that will improve the lives of patients, within Canada and around the world. Learn more at: http://ccabcanada.com/